Peer-Reviewed Journal Details
Mandatory Fields
Wiedemann, I;Bottiger, T;Bonelli, RR;Wiese, A;Hagge, SO;Gutsmann, T;Seydel, U;Deegan, L;Hill, C;Ross, P;Sahl, HG
2006
July
Molecular Microbiology
The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II
Validated
WOS: 171 ()
Optional Fields
BROAD-SPECTRUM BACTERIOCIN LACTIC-ACID BACTERIA ANTIMICROBIAL PEPTIDES STAPHYLOCOCCUS-AUREUS ANTIBIOTIC NISIN PORE FORMATION BIOSYNTHESIS MERSACIDIN MEMBRANE VESICLES
61
285
296
Lacticin 3147 is a two-peptide lantibiotic produced by Lactococcus lactis in which both peptides, LtnA1 and LtnA2, interact synergistically to produce antibiotic activities in the nanomolar concentration range; the individual peptides possess marginal (LtnA1) or no activity (LtnA2). We analysed the molecular basis for the synergism and found the cell wall precursor lipid II to play a crucial role as a target molecule. Tryptophan fluorescence measurements identified LtnA1, which is structurally similar to the lantibiotic mersacidin, as the lipid II binding component. However, LtnA1 on its own was not able to substantially inhibit cell wall biosynthesis in vitro; for full inhibition, LtnA2 was necessary. Both peptides together caused rapid K+ leakage from intact cells; in model membranes supplemented with lipid II, the formation of defined pores with a diameter of 0.6 nm was observed. We propose a mode of action model in which LtnA1 first interacts specifically with lipid II in the outer leaflet of the bacterial cytoplasmic membrane. The resulting lipid II:LtnA1 complex is then able to recruit LtnA2 which leads to a high-affinity, three-component complex and subsequently inhibition of cell wall biosynthesis combined with pore formation.
OXFORD
0950-382X
10.1111/j.1365-2958.2006.05223.x
Grant Details